CLEAR SYNERGY TECHNOLOGIES
Clear Synergy Technologies renders software development, IT infrastructure, data analytics, IT consulting and management services.
CLEAR SYNERGY TECHNOLOGIES
Social Links:
Industry:
Analytics Consulting IT Infrastructure Software
Address:
Rockville, Maryland, United States
Country:
United States
Website Url:
http://www.clear-synergy.com
Total Employee:
1+
Status:
Active
Contact:
+1-301-500-7946
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Apple Mobile Web Clips Icon Content Delivery Network Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS GStatic Google Static Content
Official Site Inspections
http://www.clear-synergy.com
- Host name: unalocated.63.wixsite.com
- IP address: 185.230.63.107
- Location: Ashburn United States
- Latitude: 39.018
- Longitude: -77.539
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20147
More informations about "Clear Synergy Technologies"
CLEAR SYNERGY OASIS 9 - Canadian Association of Interventional …
May 17, 2024 CLEAR SYNERGY OASIS 9. Author CAIC ACCI Posted on May 17, 2024. Name: CLEAR SYNERGY OASIS 9; Status: Ongoing; Study design: A 2×2 factorial randomized …See details»
Interventional Cardiology - Research Studies - PHRI
The CLEAR SYNERGY (Organization to Assess Strategies for Ischemic Syndromes OASIS 9) randomized controlled trial... View Study Publications. ongoing. COMPLETE-2 Interventional Cardiology. COMPLETE-2: A …See details»
CLEAR SYNERGY (OASIS 9) - phri.ca
CLEAR SYNERGY (OASIS 9) ... PCI and SYNERGY Stent Registry –Organization to Assess Strategies of Ischemic Syndromes 9. www.phri.ca Primary Endpoints 1. Colchicine vs. …See details»
CLEAR SYNERGY (OASIS 9) - A 2x2 factorial randomized controlled …
CLEAR SYNERGY (OASIS 9) - A 2x2 factorial randomized controlled trial of CoLchicine and spironolactonE in patients with ST elevation myocARdial infarction/SYNERGY Stent Registry …See details»
CLEAR SYNERGY (OASIS 9) A 2x2 factorial randomized controlled ...
9 - CLEAR SYNERGY (OASIS 9) A 2x2 factorial randomized controlled trial of CoLchic ... 16-12-2024 Approved WMO Date: 28-04-2022 ... A 2x2 factorial randomized controlled trial of …See details»
CLEAR SYNERGY (OASIS 9) - Health Research Authority
CLEAR SYNERGY (OASIS 9) Research type. Research Study. Full title. CLEAR SYNERGY (OASIS 9): A 2x2 factorial randomized controlled trial of CoLchicine and spironolactonE in …See details»
Spironolactone and Colchicine and SYNERGY Bioabsorbable
Feb 3, 2017 A 2x2 Factorial Randomized Controlled Trial of Colchicine and Spironolactone in Patients with Myocardial Infarction / SYNERGY Stent Registry - Organization to Assess …See details»
Colchicine in Acute Myocardial Infarction - CLEAR …
Oct 25, 2024 Colchicine’s reported effects on these endpoints, including repeat MI, urgent revascularization, and stroke, have varied across studies but were identical to placebo in CLEAR SYNERGY (OASIS 9). Although population …See details»
Colchicine Surprise: No Help Post-MI, Large CLEAR SYNERGY Trial …
Oct 29, 2024 CLEAR SYNERGY (OASIS 9) is a 2 x 2 randomized controlled trial of low-dose colchicine 0.5 mg daily versus placebo and spironolactone 25 mg daily versus placebo in …See details»
Design and rationale of the CLEAR SYNERGY (OASIS 9) trial: A 2x2 ...
Therefore, we initiated the CLEAR SYNERGY (OASIS 9) trial to address these uncertainties. Methods: The CLEAR SYNERGY trial is a 2 × 2 factorial randomized controlled trial of low …See details»
CLEAR SYNERGY (OASIS 9) - PHRI
CLEAR SYNERGY (OASIS 9) CoLchicine and spironolactonE in patients with myocARdial infarction who have undergone PCI/SYNERGY Stent Registry –Organization to Assess …See details»
Design and rationale of the CLEAR SYNERGY (OASIS 9) trial: A 2x2 ...
Sep 1, 2024 The Population Health Research Institute (PHRI) is the coordinating center for the CLEAR SYNERGY trial. The PHRI was responsible for the randomization process and …See details»
COMMENT ON: ROUTINE SPIRONOLACTONE IN ACUTE …
Dr. Bonaca is the Executive Director of CPC, a non-profit academic research organization ... CLEAR SYNERGY. Jolly S. et al. AHA 2024. 3. CV Death. or New or Worsening Heart Failure. …See details»
CLEAR SYNERGY (OASIS 9): Spironolactone vs. Placebo and …
Dec 21, 2024 New findings from CLEAR SYNERGY (OASIS 9) comparing spironolactone vs. placebo in patients with myocardial infarction (MI) found that the mineralocorticoid receptor …See details»
CLEAR SYNERGY (OASIS 9): Design and Rationale of the trial: A 2x2 ...
Homepage > Publications > CLEAR SYNERGY (OASIS 9): Design and Rationale of the trial: A 2×2 Factorial Randomized Controlled Trial of Colchicine versus placebo and Spironolactone …See details»
Place des ARM en post-infarctus en absence de défaillance …
Nov 19, 2024 Etude CLEAR SYNERGY – D’après la présentation « The CLEAR SYNERGY (OASIS 9) Trial: A 2x2 factorial randomized controlled trial of colchicine versus placebo and …See details»
Clear Synergy Technologies - Crunchbase Company Profile
Clear Synergy Technologies renders software development, IT infrastructure, data analytics, IT consulting and management services. Rockville , Maryland , United States 1-10See details»
LEADER-PAD - Research Studies - PHRI - Population Health …
CLEAR SYNERGY (OASIS 9) ... The CLEAR SYNERGY (Organization to Assess Strategies for Ischemic Syndromes OASIS 9) randomized controlled trial... View Study Publications. …See details»
CLEAR SYNERGY: Colchicine in Acute Myocardial Infarction
Don't miss out on the latest health research news from the Population Health Research Institute in Hamilton, CanadaSee details»